About Us: Difference between revisions - Compendium of Cancer Genome Aberrations

(3 intermediate revisions by the same user not shown)

Line 6:

'''Goals'''

* Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.

*Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.

* Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.

*Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.

* Engage community experts and their trainees in curating, updating and utilizing content.

*Engage community experts and their trainees in curating, updating and utilizing content.

* Include cancer variant knowledge identified through diverse methods and across multiple disciplines.

*Include cancer variant knowledge identified through diverse methods and across multiple disciplines.

* Facilitate building educational content that describes the latest advancements in the field.

*Facilitate building educational content that describes the latest advancements in the field.

Line 16:

The global hub for clinical cancer genomic aberrations.

'''Support'''

The CCGA is a [http://www.cancergenomics.org Cancer Genomics Consortium (CGC)]-supported resource.

'''Leadership'''

Meet our [[Leadership|Editorial Leadership]], [[CCGA Workgroup|CCGA Workgroup Members]] and [[Communications Liaison|Communications Liaison]].

@@ Line 6: / Line 6: @@
 '''Goals'''
-* Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
+*Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
-* Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
+*Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
-* Engage community experts and their trainees in curating, updating and utilizing content.
+*Engage community experts and their trainees in curating, updating and utilizing content.
-* Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
+*Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
-* Facilitate building educational content that describes the latest advancements in the field.
+*Facilitate building educational content that describes the latest advancements in the field.
@@ Line 16: / Line 16: @@
 The global hub for clinical cancer genomic aberrations.
+'''Support'''
+The CCGA is a [http://www.cancergenomics.org <u>Cancer Genomics Consortium (CGC)</u>]-supported resource.
 '''Leadership'''
+Meet our <u>[[Leadership|Editorial Leadership]]</u>, <u>[[CCGA Workgroup|CCGA Workgroup Members]]</u> and [[Communications Liaison|<u>Communications Liaison</u>]].
 <br />